Editing the running history of the first AI powered drug discovered in mankind.
Budget: $750 – $1,500 USD
Insilico Medicine is looking for documentary editors with a passion for science and technology to edit a 15-30min compelling documentary story of AI-powered Drug Discovery with the footage and script(optional) we provide.
A little bit of background:
With the advancement of science and technology, human being is going to Mars in a few years. However, here on the earth, over 5000 thousands disease has absolutely no cure nor effective treatment. Sadly, creating a new drug from scratch takes about 10 years and 10 billion USD in average. That means if you're unfortunately getting a deadly disease, there's no chance that you will survive without miracle. Now, AI powered drug discovery provides a strong solution to this devastating issue. It accelerates the process for years and significantly cuts the R&D cost , which makes possible for patients to hope for effective therapeutics. Over the past few years, with Insilico Medicine's proprietary Pharma.AI platform, they've developed a novel therapeutic for a deadly disease: Idiopathic Pulmonary Fibrosis. It's the first AI discovered target and the first AI-generated small molecule getting into Phase II clinical trial, which means it's currently testing in patients with the disease.
Task Description:
We are running a competition: Docuthon, to engage storytellers worldwide to build this story in your own vision. We would offer footage provide with a timeline. You are responsible for putting these footage together in a compelling fashion. It can be educational, inspirational, emotional and etc. You could focus on the impact and advancements of what AI has brought in the field of drug discovery. The purpose is to shed light on how AI has been instrumental in accelerating drug discovery, and the hurdles that the pioneers are overcoming.
Footage Inventory:
Key Opinion Leaders' Interview
Michael Levitt 2013 Nobel Lauret in Chemistry
Kaifu Lee Chairman of Sinovasion, Top 100 Leaders in AI
Jensen Huang CEO of NVIDIA
Numerous AI & Drug Discovery Industry Leaders
Insilico Medicine's CEO Interview
Dr. Alex Zhavoronkov Founder and Co-CEO
Dr. Ren Feng Co-CEO and CSO
Dr. Alex Aliper Co-Founder and President
Numerous Internal Leaders
AI Scientists Interview
Drug Discovery Scientists Interview
the building of Insilico's 6th generation robotics lab (ran by AI)
First AI-powered drug "First in Human" celebration
AI Platform demo and animation
Industry collaboration events
Ideal candidates will possess:
- Knowledge about artificial intelligence and its application in drug discovery
- Expertise in creating engaging and informative short documentaries
- effectively translate dense scientific concepts into compelling visual storytelling
- Ability to effectively convey scientific phenomena to a broad audience
The core topics covered in this project will include:
- Explanation of AI's role in discovering new drug candidates
- Illustrating the challenges in the field, and how they're being tackled
A little bit of background:
With the advancement of science and technology, human being is going to Mars in a few years. However, here on the earth, over 5000 thousands disease has absolutely no cure nor effective treatment. Sadly, creating a new drug from scratch takes about 10 years and 10 billion USD in average. That means if you're unfortunately getting a deadly disease, there's no chance that you will survive without miracle. Now, AI powered drug discovery provides a strong solution to this devastating issue. It accelerates the process for years and significantly cuts the R&D cost , which makes possible for patients to hope for effective therapeutics. Over the past few years, with Insilico Medicine's proprietary Pharma.AI platform, they've developed a novel therapeutic for a deadly disease: Idiopathic Pulmonary Fibrosis. It's the first AI discovered target and the first AI-generated small molecule getting into Phase II clinical trial, which means it's currently testing in patients with the disease.
Task Description:
We are running a competition: Docuthon, to engage storytellers worldwide to build this story in your own vision. We would offer footage provide with a timeline. You are responsible for putting these footage together in a compelling fashion. It can be educational, inspirational, emotional and etc. You could focus on the impact and advancements of what AI has brought in the field of drug discovery. The purpose is to shed light on how AI has been instrumental in accelerating drug discovery, and the hurdles that the pioneers are overcoming.
Footage Inventory:
Key Opinion Leaders' Interview
Michael Levitt 2013 Nobel Lauret in Chemistry
Kaifu Lee Chairman of Sinovasion, Top 100 Leaders in AI
Jensen Huang CEO of NVIDIA
Numerous AI & Drug Discovery Industry Leaders
Insilico Medicine's CEO Interview
Dr. Alex Zhavoronkov Founder and Co-CEO
Dr. Ren Feng Co-CEO and CSO
Dr. Alex Aliper Co-Founder and President
Numerous Internal Leaders
AI Scientists Interview
Drug Discovery Scientists Interview
the building of Insilico's 6th generation robotics lab (ran by AI)
First AI-powered drug "First in Human" celebration
AI Platform demo and animation
Industry collaboration events
Ideal candidates will possess:
- Knowledge about artificial intelligence and its application in drug discovery
- Expertise in creating engaging and informative short documentaries
- effectively translate dense scientific concepts into compelling visual storytelling
- Ability to effectively convey scientific phenomena to a broad audience
The core topics covered in this project will include:
- Explanation of AI's role in discovering new drug candidates
- Illustrating the challenges in the field, and how they're being tackled